Hw. Demian et K. Mcdermott, REGULATORY PERSPECTIVE ON CHARACTERIZATION AND TESTING OF ORTHOPEDIC BONE CEMENTS, Biomaterials, 19(17), 1998, pp. 1607-1618
This paper provides a general regulatory background of acrylic bone ce
ments, chemical composition information on several commercially availa
ble bone cements, physical and chemical methods of analyses, mechanica
l test methods, and risks and failure mechanisms of acrylic bone cemen
ts. Suggestions and recommendations presented in Tables 2 and 3 are no
t mandatory requirements but reflect data and methodologies which the
FDA's Orthopedic Devices Branch (ORDB) believes to be acceptable to ev
aluate most pre-clinical data. FDA may require information in addition
to that contained in this paper. In some instances, a sponsor may be
able to sufficiently justify the omission of some tests. Although this
paper describes certain administrative requirements, it does not take
the place of the requirements contained in Title 21 of the Code of Fe
deral Regulations (21 CFR) Parts 801, 807, 812, and 814 or those found
in the statute. (C) 1998 Elsevier Science Ltd. All rights reserved.